Real-World Outcomes Following Dose Modifications of First-Line Ibrutinib in Patients with Waldenstrom Macroglobulinemia

被引：0
|
作者：
Sarosiek, Shayna R. [1 ]
von Keudell, Gottfried R. [2 ]
Paludo, Jonas [3 ]
Salkar, Monika [4 ]
Agatep, Barnabie [5 ]
Franco, Anjali [5 ]
Crawford, Samuel [4 ]
Pacia, Michelle [4 ]
Castillo, Jorge J. [2 ,6 ]
机构：
[1] Dana Farber Canc Inst, Bing Ctr Waldenstrom Macroglobulinemia, Boston, MA 02115 USA
[2] Harvard Med Sch, Boston, MA 02115 USA
[3] Mayo Clin, Rochester, MN USA
[4] AbbVie, N Chicago, IL 60064 USA
[5] Inovalon, Bowie, MD USA
[6] Dana Farber Canc Inst, Boston, MA 02115 USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-181925
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Real-World Treatment Patterns and Healthcare Resource Utilization in Patients with Waldenstrom Macroglobulinemia Initiating First-Line Treatment with Ibrutinib or Zanubrutinib
    Paludo, Jonas
    Sarosiek, Shayna R.
    von Keudell, Gottfried R.
    Salkar, Monika
    Zhou, Summera
    Kim, Sonia
    Cheng, Ning
    Pacia, Michelle
    Karve, Sudeep
    Castillo, Jorge J.
    BLOOD, 2023, 142
  • [2] Real-World Dosing Patterns and Outcomes Among Patients With Chronic Lymphocytic Leukemia With or Without Dose Adjustment of First-Line Ibrutinib
    Rogers, Kerry
    Lu, Xiaoxiao
    Emond, Bruno
    Ding, Zhijie
    Lefebvre, Patrick
    Lafeuille, Marie-Helene
    Mavani, Heena
    Qureshi, Zaina
    Ghosh, Nilanjan
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S330 - S330
  • [3] Comparison of Zanubrutinib and Ibrutinib As Treatments for Waldenstrom Macroglobulinemia: A Real-World Retrospective Study
    Iadevaia, Francesco
    Hafer, Ramsay
    Rohan, Thomas Z.
    Khoo, Alan
    Laurenti, Luca
    Porcu, Pierluigi
    BLOOD, 2024, 144 : 5111 - 5112
  • [4] Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status
    Qing Huang
    Kathleen L. Deering
    Qing Harshaw
    Lori A. Leslie
    Advances in Therapy, 2022, 39 : 3292 - 3307
  • [5] Real-world Clinical Outcomes of First-Line Ibrutinib or Chemoimmunotherapy in Patients with Chronic Lymphocytic Leukemia by Risk Status
    Huang, Qing
    Deering, Kathleen L.
    Harshaw, Qing
    Leslie, Lori A.
    ADVANCES IN THERAPY, 2022, 39 (07) : 3292 - 3307
  • [6] Real World Experience on the Use of Ibrutinib Monotherapy in Waldenstrom Macroglobulinemia
    Ogunbiyi, Olabisi
    Arulogun, Suzanne O.
    Patel, Aisha
    Rismani, Ali
    Kyriakou, Charalampia
    D'Sa, Shirley
    BLOOD, 2021, 138
  • [7] Outcomes of marginal zone lymphoma treated with ibrutinib in the first-line setting in the United States: a real-world analysis
    Epperla, Narendranath
    Zhao, Qiuhong
    Moyo, Tamara
    Watkins, Marcus P.
    Tavakkoli, Montreh
    Bello, Celeste
    Torka, Pallawi
    Reddy, Nishitha
    Thomas, Colin
    Annunzio, Kaitlin
    Christian, Beth
    Barta, Stefan K.
    Shouse, Geoffrey
    Olszewski, Adam J.
    Bartlett, Nancy L.
    BLOOD ADVANCES, 2024, 8 (03) : 549 - 552
  • [8] Real-world outcomes following adverse events and dose reduction of first-line ibrutinib in Medicare beneficiaries with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
    Shadman, Mazyar
    Srivastava, Bhavini P.
    Salkar, Monika
    Saifan, Chadi
    Agatep, Barnabie C.
    Jones, Barton
    Ryan, Olga
    Bacchus, Shaffee
    Stephens, Deborah M.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] First-Line Treatment Outcomes of CML Patients in a Real-World Data Setting in Lebanon
    Nasr, Fadi
    Yehia, Intissar
    El Khoury, Reem
    Diab, Saada
    Al Ghoche, Ahmad
    Nasr, Lewis
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2021, 21 : S332 - S333
  • [10] Ibrutinib As a Promising Treatment for Heavily Pretreated Waldenstrom Macroglobulinemia: A Real World Data
    Ilhan, Osman
    Seval, Guldane Cengiz
    Avcu, Ferit
    Ferhanoglu, Burhan
    Cetin, Guven
    Kurtoglu, Erdal
    Atalay, Figen
    Gulturk, Emine
    Nalcaci, Meliha
    Beksac, Meral
    BLOOD, 2020, 136
12345